Literature DB >> 1698610

Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor.

Y Nophar1, O Kemper, C Brakebusch, H Englemann, R Zwang, D Aderka, H Holtmann, D Wallach.   

Abstract

Two proteins which specifically bind tumor necrosis factor (TNF) have recently been isolated from human urine in our laboratory. The two proteins cross-react immunologically with two species of cell surface TNF receptors (TNF-R). Antibodies against one of the two TNF binding proteins (TBPI) were found to have effects characteristic of TNF, including stimulating phosphorylation of specific cellular proteins. Oligonucleotide probes designed on the basis of the NH2-terminal amino acid sequence of TBPI were used to clone the cDNA for the structurally related cell surface type 1 TNF-R. It is notable that although this receptor can signal the phosphorylation of cellular proteins, it appears from its amino acid sequence to be devoid of intrinsic protein kinase activity. The extracellular domain of the receptor is composed of four internal cysteine-rich repeats, homologous to structures repeated four times in the extracellular domains of the nerve growth factor receptor and the B lymphocytes surface antigen CDw40. The amino acid composition and size of the extracellular domain of the type I TNF-R closely resemble those of TBPI. The COOH-terminal amino acid sequence of the four cysteine rich repeats within the extracellular domain of the type I TNF-R matches the COOH-terminal sequence of TBPI. Amino acid sequences in the extracellular domain also fully match other sequences found in TBPI. On the other hand, amino acid sequences in the soluble form of the type II TNF-R (TBPII), while indicating a marked homology of structure, did not suggest any identity between this protein and the extracellular domain of the type I TNF-R. CHO cells transfected with type I TNF-R cDNA produced both cell surface and soluble forms of the receptor. The receptor produced by CHO cells was recognized by several monoclonal antibodies against TBPI, reacting with several distinct epitopes in this molecule. These data suggest that the soluble forms of the TNF-Rs are structurally identical to the extracellular cytokine binding domains of these receptors and are consistent with the notion that the soluble forms are, at least partly, derived from the same transcripts that encode the cell surface receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698610      PMCID: PMC552060          DOI: 10.1002/j.1460-2075.1990.tb07526.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  52 in total

1.  CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.

Authors:  G E FOLEY; H LAZARUS; S FARBER; B G UZMAN; B A BOONE; R E MCCARTHY
Journal:  Cancer       Date:  1965-04       Impact factor: 6.860

Review 2.  Tumor necrosis, cachexia, shock, and inflammation: a common mediator.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

3.  Gene transfer and molecular cloning of the rat nerve growth factor receptor.

Authors:  M J Radeke; T P Misko; C Hsu; L A Herzenberg; E M Shooter
Journal:  Nature       Date:  1987 Feb 12-18       Impact factor: 49.962

4.  Co-existence of vinculin and a vinculin-like protein of higher molecular weight in smooth muscle.

Authors:  J R Feramisco; J E Smart; K Burridge; D M Helfman; G P Thomas
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

5.  Structure-function relationships for the IL 2-receptor system. IV. Analysis of the sequence and ligand-binding properties of soluble Tac protein.

Authors:  R J Robb; R M Kutny
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

6.  Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate.

Authors:  H Holtmann; D Wallach
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

7.  Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity.

Authors:  F C Kull; S Jacobs; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.

Authors:  M Tsujimoto; Y K Yip; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

9.  Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition.

Authors:  C Baglioni; S McCandless; J Tavernier; W Fiers
Journal:  J Biol Chem       Date:  1985-11-05       Impact factor: 5.157

10.  Lambda ZAP: a bacteriophage lambda expression vector with in vivo excision properties.

Authors:  J M Short; J M Fernandez; J A Sorge; W D Huse
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

View more
  51 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  14-Deoxyandrographolide desensitizes hepatocytes to tumour necrosis factor-alpha-induced apoptosis through calcium-dependent tumour necrosis factor receptor superfamily member 1A release via the NO/cGMP pathway.

Authors:  D N Roy; S Mandal; G Sen; S Mukhopadhyay; T Biswas
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Oligomeric tumour necrosis factor alpha slowly converts into inactive forms at bioactive levels.

Authors:  A Corti; G Fassina; F Marcucci; E Barbanti; G Cassani
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

4.  The gene for the type 1 tumor necrosis factor receptor (TNF-R1) is localized on band 12p13.

Authors:  J Derré; O Kemper; D Cherif; Y Nophar; R Berger; D Wallach
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

5.  Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor.

Authors:  R G Goodwin; D Anderson; R Jerzy; T Davis; C I Brannan; N G Copeland; N A Jenkins; C A Smith
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

6.  Molecular cloning and expression of the mouse Tnf receptor type b.

Authors:  J G Rothe; M Brockhaus; R Gentz; W Lesslauer
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

7.  Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation.

Authors:  O M Howard; K A Clouse; C Smith; R G Goodwin; W L Farrar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

Review 8.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

9.  Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.

Authors:  C Ferran; F Dautry; S Mérite; K Sheehan; R Schreiber; G Grau; J F Bach; L Chatenoud
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

10.  Increased release of the tumour necrosis factor receptor p75 by immortalized human keratinocytes results from an activated shedding mechanism and is not related to augmented steady-state levels of p75 mRNA.

Authors:  P Neuner; M Pourmojib; G Klosner; F Trautinger; R Knobler
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.